Ferric Carboxymaltose Injection

Ferric Carboxymaltose Injection

Ferric Carboxymaltose Injection is an intravenous iron preparation used to treat iron deficiency anemia (IDA) in adults when oral iron therapy is ineffective, intolerable, or not feasible. It offers rapid iron replenishment in a single or limited number of doses, improving hemoglobin levels quickly and effectively.

This injection contains Ferric Carboxymaltose, a stable iron complex designed for controlled iron release. It allows the administration of high doses in a single infusion without the risk of free iron toxicity. The formulation ensures efficient iron delivery directly to the body’s iron stores, bypassing gastrointestinal absorption issues commonly seen with oral iron supplements.

  • Treatment of iron deficiency anemia due to chronic blood loss, chronic kidney disease, or inflammatory bowel diseases.
  • Correction of anemia in pregnant or postpartum women under medical supervision.
  • Rapid hemoglobin improvement compared to oral therapy.
  • Fewer doses required for total iron replenishment.
  • Well-tolerated with a good safety profile when administered correctly.